Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 19681-19690 Newer>

The Motley Fool January 9, 2007 Matthew Crews	Supervalu: The Price of Embiggening Profits are still far off for this supermarket giant. Investors, take note.
The Motley Fool January 9, 2007 Rich Smith	Cuts Like a Razr Poor Motorola just can't catch a break. No sooner had the firm's shares stabilized after last week's earnings warning, then out comes Steve Jobs of Apple with the introduction of his firm's much-heralded iPhone.
The Motley Fool January 9, 2007 Rich Smith	Chavez Plays Double or Nothing Until yesterday, investors in Venezuelan telecom CA Nacional Telefonos de Venezuela had been feeling pretty good about their stock.
The Motley Fool January 9, 2007 Rich Duprey	Foolish Forecast: The Ticker on TD Ameritrade The discount broker is set to report first-quarter 2007 results. Here's what investors can expect to see.
The Motley Fool January 9, 2007 Tom Taulli	Media M&A: Partying Like It Was 2000 A media investment bank examines 2006's deal-making -- and forecasts 2007. Investors, take note.
The Motley Fool January 9, 2007 Brian Lawler	ViroPharma's Healthy Sales Guidance The coming year looks like another strong one for the drug developer. This small-cap pharmaceutical stock is worth taking a look at just for its cheap valuation.
The Motley Fool January 9, 2007 Rich Duprey	Schnitzer Steel's Dull Metal Profits slide, affecting most segments of the scrap metal recycler. That these metals seem to be on the retreat now may mean that the cycle is on the wane, and there may be a time when an investor can get in on Schnitzer at a lower price.
The Motley Fool January 9, 2007 Rick Aristotle Munarriz	Denim and Dumber at Gap The specialty retailer may finally have an exit strategy. Clearly, Gap is broken. The real question: Can it be fixed? Investors, take note.
The Motley Fool January 9, 2007 Selena Maranjian	How to Earn a 3,017% Return In exchange for his $35 investment in each share of Pfizer stock 47 years ago, this 98-year-old is now receiving $1,056 per share each year. That's some payback, eh?
The Motley Fool January 9, 2007 Matthew Crews	TJX: No Longer on Sale The off-price retailer's fortunes have rebounded, and its stock has followed suit.
<Older 19681-19690 Newer> Return to current articles.